GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Entourage Health Corp (OTCPK:ETRGF) » Definitions » YoY EBITDA Growth

Entourage Health (Entourage Health) YoY EBITDA Growth : 87.44% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Entourage Health YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Entourage Health's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 87.44%.

Entourage Health's EBITDA per Share for the three months ended in Dec. 2023 was $-0.03.


Entourage Health YoY EBITDA Growth Historical Data

The historical data trend for Entourage Health's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entourage Health YoY EBITDA Growth Chart

Entourage Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,800.00 -396.55 32.99 -25.39 78.51

Entourage Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -111.70 - -80.00 72.41 87.44

Entourage Health YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Entourage Health's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.052--0.242)/ | -0.242 |
=78.51 %

Entourage Health's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(-0.025--0.199)/ | -0.199 |
=87.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Entourage Health YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Entourage Health's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Entourage Health (Entourage Health) Business Description

Traded in Other Exchanges
Address
250 Elm Street, Aylmer, ON, CAN, N5H 2M8
Entourage Health Corp is a licence holder producing and distributing cannabis products for both the medical and adult-use markets. It owns and operates greenhouse, outdoor, and processing facility located in Strathroy as well as a fully licensed Aylmer processing facility, specializing in cannabis extraction. With the addition of Starseed Medicinal, a medical-centric brand, it has expanded its multi-channeled distribution. The company operates in one segment, the production and sale of cannabis in Canada.